Helene and CVS land double whammy for 25,000 patients who survive on IV nutrition

The CVS representative popped into Lisa Trumble’s third-floor Berkshire Medical Center hospital room in Pittsfield, Massachusetts, to announce that everything was arranged for Trumble to return home, where she relies on IV nutrition because of severe intestinal problems that leave her unable to eat.

Former RayzeBio CEO quickly returns with new biotech; Amgen’s global research leader steps down

Ken Song is back in business. He left RayzeBio in February after leading the radiopharmaceuticals startup from Series A to IPO in three years, and

August 3, 2024

Taiho exercises option for Arcus Biosciences’ quemliclustat in Asia

The asset is currently being investigated as a potential treatment for metastatic pancreatic ductal adenocarcinoma. MattL_Images/Shutterstock. Taiho Pharmaceutical has exercised an option for an exclusive

July 9, 2024

Onset and prognosis of post-COVID-19 condition: A 2-Year observational study

Researchers conducted a prospective cohort analysis over two years.

September 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.